In the past few decades, the field of autologous cell therapy (ACT) has been witnessed rapid evolution and a surge in research activities aimed at the realization of the potential benefits of use of biosynthetic composites for a variety of human conditions. With successful products such as plasmids for the bulk production of therapeutic proteins, recombinant human insulin, and artificial organs, autologous cell therapy has continued to gain an increasing amount of interest from the scientific community.
In a recent market research report, Transparency Market Research (TMR) identifies and analyzes the excellent growth prospects of the global autologous cell therapy market over the period between 2016 and 2024. The report states that the market will exhibit a remarkable 22% CAGR over the said period and rise from a valuation of US$3.8 bn in 2015 to US$23.7 bn by 2024.
Obtain Report Details @ http://www.transparencymarketresearch.com/autologus-cell-therapy-market.html
In this blog post, TMR analysts highlight some of the most trending aspects of the global autologous cell therapy market:
Q. What are the key advantages of autologous cell therapy interventions over conventional treatments?
A. Autologous cell therapy interventions lead to a minimized risk of complications arising from bio-incompatibility, immunological reactions, and the potential chances of disease transmission, commonly associated with cell cultivated from a foreign source. The use of cells and grafts that are sourced from the same individual that is supposed to be the one to use the bioengineered substitutes has showed effective results in areas such as treatment of burns and pressure ulcers, fast healing of wounds, and improves postoperative or post implantation healing.
However, factors such as the existing lag between the processes of extraction and cultivation of biological cells and their actual usage and the effect of certain growth factors and extrinsic factors on the efficacy, specificity, and functionality could hamper the overall usability of bioengineered substances.
Q. What are some of the most researched areas of application of autologous cell therapy?
A. The use of autologous cell therapy for corrective surgeries or cosmetic enhancements is one of the present times’ most researched areas of application of ACT. The healthcare industry is increasingly considering ACT as one of the most creditable forms of treatment as it leads to a reduction in the risk of rejection and provides effects that are longer lasting than most conventional biotechnological treatments.
The world’s population is rapidly aging and the demand for corrective surgeries or cosmetic enhancements is significantly rising despite the availability of a large number of injectable substances for the augmentation of soft tissues. As a result, research in the field of developing longer lasting and clinically more effective dermal fillers remains strong. The use of ACT is potentially present times’ best solution and is witnessing intense investigation, with the hope that it will be able to effectively replace conventional forms of cosmetic enhancement practices to improve the treatment of damaged tissues.